🔍 RecallPedia

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

Class I - Dangerous
💊 Drugs Recalled: March 19, 2021 Asclemed USA Inc. Prescription Drugs

What Should You Do?

  1. Check if you have this product:
    Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Reason for Recall:
Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

Product Codes/Lot Numbers:

Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022

Distribution:

Distributed in: CA, LA, AL

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0330-2021

Related Recalls